tiprankstipranks
MGC Pharmaceuticals (AU:MXC)
ASX:MXC

MGC Pharmaceuticals (MXC) Ownership - Who Owns MGC Pharmaceuticals?

0 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 18, 2023
Yifat Steuer
Chief Operating Officer & Deputy Chief Executive
Bought£7000
Jul 18, 2023
Yair Tal
Chief Information Security Officer
Bought£2600
Jul 18, 2023
Amir Polak
Chief Technical Officer
Bought£5300
Jul 18, 2023
Itay Nissim
Chief Operations Officer
Bought£4600

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
53,000,000Insider117.05%21,730,000
33,819,673Insider74.69%13,866,066
30,960,558Insider68.38%12,693,829
20,979,628Insider46.33%8,601,647
19,718,602Insider43.55%8,084,627
11,780,296Insider26.02%4,829,921
9,544,190Insider21.08%3,913,118
4,970,370Insider10.98%2,037,852
4,600,000Insider10.16%1,886,000
3,185,148Insider7.03%1,305,911

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns MGC Pharmaceuticals (AU:MXC)?
Currently, no data Available
What percentage of MGC Pharmaceuticals (AU:MXC) stock is held by institutional investors?
Currently, no data Available
What percentage of MGC Pharmaceuticals (AU:MXC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of MGC Pharmaceuticals (AU:MXC)?
Nativ Segev owns the most shares of MGC Pharmaceuticals (AU:MXC).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis